OrthoPediatrics Corp. (NASDAQ:KIDS) is recommended as one of the best medical device stocks to buy by analysts. A JMP analyst lowered the price target to $35 from $50 while maintaining an Outperform rating. The company reported a quarterly record on its top line, despite slightly missing adjusted EBITDA and revenue consensus. Management reiterated full-year guidance and continues to gain market share in key segments. OrthoPediatrics Corp. specializes in designing implants and devices for children with orthopedic conditions, such as sports injuries and deformities. While KIDS shows potential as an investment, other AI stocks may offer greater upside and lower risk. For more insights on AI stocks, refer to the detailed report.

Read more at Yahoo Finance: Citizens JMP Slashes PT on OrthoPediatrics (KIDS) to $35 From $50, Keeps an Outperform Rating